Cargando…

Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer

Alternative splicing (AS) has a critical role in tumor progression and prognosis. Our study aimed to investigate pancreatic cancer-specific AS events using RNA-seq data, gaining systematic insights into potential prognostic predictors. We downloaded 10,623 genes with 45,313 pancreatic cancer-specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Min, Hong, Weifeng, Ruan, Shiye, Guan, Renguo, Tu, Lei, Huang, Bowen, Hou, Baohua, Jian, Zhixiang, Ma, Liheng, Jin, Haosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736558/ https://www.ncbi.nlm.nih.gov/pubmed/31552163 http://dx.doi.org/10.3389/fonc.2019.00773

Ejemplares similares

Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis
por: Yu, Min, et al.
Publicado: (2019)

The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis
por: Jin, Liang, et al.
Publicado: (2020)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Development of a Nomogram to Predict Disease-Specific Survival for Patients After Resection of a Non-Metastatic Adenocarcinoma of the Pancreatic Body and Tail
por: Zou, Yiping, et al.
Publicado: (2020)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival
por: Guan, Renguo, et al.
Publicado: (2020)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival
por: Geng, Yan, et al.
Publicado: (2020)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Regulation of iron metabolism and ferroptosis in cancer stem cells
por: Wang, Hailiang, et al.
Publicado: (2023)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020)

Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer
por: Wu, Jian, et al.
Publicado: (2021)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

A Comprehensive Exploration of the lncRNA CCAT2: A Pan-Cancer Analysis Based on 33 Cancer Types and 13285 Cases
por: Huang, Bowen, et al.
Publicado: (2020)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
por: Liu, Yunze, et al.
Publicado: (2022)

Dissecting the effects of METTL3 on alternative splicing in prostate cancer
por: Wang, Lin, et al.
Publicado: (2023)

Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial–mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway
por: Lin, Ye, et al.
Publicado: (2020)

Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience
por: Zheng, Zehao, et al.
Publicado: (2022)

Systematic Profiling of Alternative Splicing Events in Ovarian Cancer
por: Liu, Jia, et al.
Publicado: (2021)

Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets
por: Zhou, Yu, et al.
Publicado: (2019)

The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
por: Yu, Min, et al.
Publicado: (2017)

A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma
por: Lewis, Clayton S., et al.
Publicado: (2021)

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer
por: Shi, Jian-yu, et al.
Publicado: (2021)

Alternative splicing event associated with immunological features in bladder cancer
por: Yu, Xinbo, et al.
Publicado: (2023)

The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma
por: Lin, Ye, et al.
Publicado: (2020)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
por: Jia, Keren, et al.
Publicado: (2019)

Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
por: Murphy, Anthony J., et al.
Publicado: (2022)

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Thyroid Carcinoma
por: Han, Baoai, et al.
Publicado: (2021)

Emerging roles of alternative RNA splicing in oral squamous cell carcinoma
por: Liu, Miaomiao, et al.
Publicado: (2022)

Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer
por: Yu, Wei, et al.
Publicado: (2022)

Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer
por: Wang, Lin, et al.
Publicado: (2020)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis
por: Chen, Xueran, et al.
Publicado: (2019)

Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism
por: Biamonti, Giuseppe, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t2ulu5fi6rq45ioucp77ko4ot6